Oct 15
|
Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
|
Aug 6
|
Omega Therapeutics, Inc. (OMGA) Reports Q2 Loss, Tops Revenue Estimates
|
Aug 6
|
Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
|
Aug 6
|
Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner
|
Jun 24
|
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
|
May 8
|
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
|
May 7
|
Omega Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
|
May 6
|
Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Tops Revenue Estimates
|
May 6
|
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
|
Apr 25
|
Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
Apr 23
|
Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
|
Apr 17
|
Omega Therapeutics (OMGA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
|
Apr 9
|
Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control
|
Apr 3
|
Omega Therapeutics (OMGA) Upgraded to Buy: Here's What You Should Know
|
Mar 29
|
We Think Omega Therapeutics (NASDAQ:OMGA) Needs To Drive Business Growth Carefully
|
Mar 28
|
Omega Therapeutics, Inc. (OMGA) Reports Q4 Loss, Tops Revenue Estimates
|
Mar 28
|
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
|
Mar 6
|
Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024
|
Jan 10
|
The 3 Best Biotech Stocks to Buy in January 2024
|
Dec 4
|
Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
|